Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M279Revenue $M104Net Margin (%)-124.1Altman Z-Score-1.6
Enterprise Value $M136EPS $-2.7Operating Margin %-121.8Piotroski F-Score--
P/E(ttm)--Beneish M-Score107Pre-tax Margin (%)-123.5Higher ROA y-yN
Price/Book2.110-y EBITDA Growth Rate %--Quick Ratio4.0Cash flow > EarningsN
Price/Sales2.75-y EBITDA Growth Rate %-24.3Current Ratio4.0Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-40.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-81.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M49.2ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with INFI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INFIGeorge Soros 2013-06-30 Sold Out -0.02%$16.192 - $50.09
($30.95)
$ 5.67-82%Sold Out0
INFIGeorge Soros 2013-03-31 Reduce-0.01%$32.93 - $49.37
($39.51)
$ 5.67-86%Reduce -46.67%40,000
INFIGeorge Soros 2012-12-31 Buy 0.03%$17.74 - $35.04
($25.26)
$ 5.67-78%New holding75,000
INFIFirst Eagle Investment 2012-06-30 Sold Out -0.01%$11.71 - $13.76
($12.78)
$ 5.67-56%Sold Out0
INFIFirst Eagle Investment 2012-03-31 Reduce-0.01%$5.9781 - $12.16
($7.96)
$ 5.67-29%Reduce -54.94%180,000
INFIFirst Eagle Investment 2011-09-30 Reduce-0.01%$6.17 - $10.36
($7.87)
$ 5.67-28%Reduce -25.85%464,241
INFIWilbur Ross 2011-06-30 Sold Out $5.61 - $8.19
($6.53)
$ 5.67-13%Sold Out0
INFIWilbur Ross 2010-12-31 Reduce-0.02%$5.12 - $6.86
($6.13)
$ 5.67-8%Reduce -63.91%7,415
INFIFirst Eagle Investment 2010-12-31 Add0.01%$5.12 - $6.86
($6.13)
$ 5.67-8%Add 60.34%585,437
INFIWilbur Ross 2010-09-30 Reduce-0.01%$4.62 - $6.3
($5.51)
$ 5.673%Reduce -25.39%20,545
INFIFirst Eagle Investment 2010-09-30 Add$4.62 - $6.3
($5.51)
$ 5.673%Add 29.72%365,123
INFIFirst Eagle Investment 2010-06-30 Add0.01%$5.88 - $7.94
($6.59)
$ 5.67-14%Add 566.95%281,460
INFIFirst Eagle Investment 2009-12-31 Add$5.5 - $6.57
($5.92)
$ 5.67-4%Add 451.43%42,201
INFIFirst Eagle Investment 2009-09-30 Buy $5.42 - $8.8
($6.97)
$ 5.67-19%New holding7,653
INFIWilbur Ross 2009-03-31 Buy 0.12%$7.1 - $8.28
($7.9)
$ 5.67-28%New holding28,437
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INFI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


INFI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Perkins Adelene QPresident & CEO 2015-06-25Sell5,000$10.93-48.12view
Palombella Vito J.Chief Scientific Officer 2015-06-15Sell4,737$10.97-48.31view
Perkins Adelene QPresident & CEO 2015-05-27Sell10,000$12.81-55.74view
Perkins Adelene QPresident & CEO 2015-05-14Sell10,000$12.18-53.45view
Perkins Adelene QPresident & CEO 2015-03-16Sell20,000$16-64.56view
Perkins Adelene QPresident & CEO 2015-03-05Sell25,000$16.5-65.64view
Perkins Adelene QPresident & CEO 2015-01-29Sell20,000$14.83-61.77view
Perkins Adelene QPresident & CEO 2015-01-29Sell20,000$14.83-61.77view
Palombella Vito J.Chief Scientific Officer 2014-12-15Sell4,737$16.32-65.26view
Palombella Vito J.Chief Scientific Officer 2014-11-26Sell4,736$15-62.2view

Quarterly/Annual Reports about INFI:

    News about INFI:

    Articles On GuruFocus.com
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 04 2010 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) May 06 2010 
    INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 06 2009 
    Infinity Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2009 

    More From Other Websites
    Infinity Announces the Date of Its Full-Year 2015 Financial Results Conference Call and Webcast Feb 09 2016
    Can Infinity Pharmaceuticals (INFI) Keep the Earnings Streak Alive This Quarter? Jan 15 2016
    Biotechnology Equities Scrutiny -- Advaxis, Raptor Pharma, Vanda Pharma, and Infinity Pharma Jan 14 2016
    Infinity Provides Key 2016 Goals and Financial Guidance Jan 11 2016
    INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 11 2016
    Infinity Provides Key 2016 Goals and Financial Guidance Jan 11 2016
    Infinity to Present at J.P. Morgan Annual Healthcare Conference Jan 06 2016
    Infinity to Present at J.P. Morgan Annual Healthcare Conference Jan 06 2016
    Technical Coverage on Biotechnology Stocks - Agenus, Progenics Pharma, Arrowhead Research, and... Dec 28 2015
    INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Dec 22 2015
    Pre-market Equity Watch on Biotechnology -- Agenus, Arrowhead Research, Spectrum Pharma, and... Dec 18 2015
    INFINITY PHARMACEUTICALS, INC. Financials Dec 08 2015
    How Top Money Managers Are Trading Infinity Pharmaceuticals Inc. (INFI) Dec 02 2015
    What do Hedge Funds Think of Zumiez Inc. (ZUMZ)? Nov 28 2015
    Inovio Pharmaceuticals Inc (INO): Hedge Fund Sentiment Unchanged Nov 25 2015
    Medidata's RBM Solution Picked by Infinity Pharmaceuticals Nov 24 2015
    Medidata's Risk-Based Monitoring Solution Selected by Infinity Pharmaceuticals to Advance Oncology... Nov 23 2015
    Perkins looks to Infinity and beyond, to becoming a commercial-stage drugmaker Nov 19 2015
    Infinity (INFI) Completes Enrollment in Phase III DUO Study Nov 18 2015
    Infinity Announces Completion Of Target Enrollment In DUO™, A Phase 3 Study Evaluating duvelisib... Nov 17 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK